跳至主要内容
临床试验/ACTRN12610000428066
ACTRN12610000428066已完成4 期

A randomised double blind, placebo controlled, cross-over study of the effect of amiloride over 6 weeks, on renal water handling in individuals with a bipolar or unipolar disorder, requiring lithium therapy

Health Research Council of New Zealand0 个研究点目标入组 10 人开始时间: 2010年5月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Inclusion criteria.
  • All patients aged 18 to 60, with a bipolar or unipolar affective disorder requiring the commencement of lithium to manage their psychiatric disorder, and who are able to give informed consent.

排除标准

  • Exclusion criteria.
  • Any individual who is unable to give informed consent.
  • Any patients with evidence of renal impairment (plasma creatinine > 0.12 mmol/l)
  • Any patient unable to comply with a fluid restriction.
  • Any previous exposure to lithium
  • Pregnancy, thyroid disease.
  • Any contraindication to amiloride.
  • Thiazide or Angiotensin converting enzyme inhibitors, requirement for potassium supplements.

研究者

相似试验